vs
礼蓝动物保健（ELAN）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
罗致恒富的季度营收约是礼蓝动物保健的1.1倍（$1.3B vs $1.1B），礼蓝动物保健同比增速更快（12.2% vs -5.8%），罗致恒富自由现金流更多（$170.8M vs $46.0M），过去两年礼蓝动物保健的营收复合增速更高（-2.6% vs -6.1%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
ELAN vs RHI — 直观对比
营收规模更大
RHI
是对方的1.1倍
$1.1B
营收增速更快
ELAN
高出17.9%
-5.8%
自由现金流更多
RHI
多$124.8M
$46.0M
两年增速更快
ELAN
近两年复合增速
-6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.3B |
| 净利润 | $-276.0M | — |
| 毛利率 | 51.5% | 37.6% |
| 营业利润率 | -22.6% | 1.7% |
| 净利率 | -24.1% | — |
| 营收同比 | 12.2% | -5.8% |
| 净利润同比 | -3350.0% | — |
| 每股收益（稀释后） | $-0.55 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANRHI
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.2B | $1.4B | ||
| Q4 24 | $1.0B | $1.4B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $1.2B | $1.5B | ||
| Q1 24 | $1.2B | $1.5B |
净利润ELANRHI
| Q4 25 | $-276.0M | — | ||
| Q3 25 | $-34.0M | $42.9M | ||
| Q2 25 | $11.0M | $41.0M | ||
| Q1 25 | $67.0M | $17.4M | ||
| Q4 24 | $-8.0M | — | ||
| Q3 24 | $364.0M | $65.5M | ||
| Q2 24 | $-50.0M | $68.2M | ||
| Q1 24 | $32.0M | $63.7M |
毛利率ELANRHI
| Q4 25 | 51.5% | 37.6% | ||
| Q3 25 | 53.4% | 37.2% | ||
| Q2 25 | 57.5% | 37.2% | ||
| Q1 25 | 57.3% | 36.9% | ||
| Q4 24 | 50.9% | 38.8% | ||
| Q3 24 | 52.2% | 39.0% | ||
| Q2 24 | 58.2% | 39.2% | ||
| Q1 24 | 57.3% | 38.1% |
营业利润率ELANRHI
| Q4 25 | -22.6% | 1.7% | ||
| Q3 25 | -4.4% | 1.0% | ||
| Q2 25 | 2.0% | 0.1% | ||
| Q1 25 | 5.0% | 2.9% | ||
| Q4 24 | -5.0% | 4.7% | ||
| Q3 24 | 54.3% | 4.1% | ||
| Q2 24 | -2.7% | 5.1% | ||
| Q1 24 | 1.0% | 2.8% |
净利率ELANRHI
| Q4 25 | -24.1% | — | ||
| Q3 25 | -3.0% | 3.2% | ||
| Q2 25 | 0.9% | 3.0% | ||
| Q1 25 | 5.6% | 1.3% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 35.3% | 4.5% | ||
| Q2 24 | -4.2% | 4.6% | ||
| Q1 24 | 2.7% | 4.3% |
每股收益（稀释后）ELANRHI
| Q4 25 | $-0.55 | $0.32 | ||
| Q3 25 | $-0.07 | $0.43 | ||
| Q2 25 | $0.02 | $0.41 | ||
| Q1 25 | $0.13 | $0.17 | ||
| Q4 24 | $-0.01 | $0.53 | ||
| Q3 24 | $0.73 | $0.64 | ||
| Q2 24 | $-0.10 | $0.66 | ||
| Q1 24 | $0.06 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $464.4M |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $6.5B | $1.3B |
| 总资产 | $13.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资ELANRHI
| Q4 25 | $545.0M | $464.4M | ||
| Q3 25 | $505.0M | $365.3M | ||
| Q2 25 | $539.0M | $380.5M | ||
| Q1 25 | $487.0M | $342.5M | ||
| Q4 24 | $468.0M | $537.6M | ||
| Q3 24 | $490.0M | $570.5M | ||
| Q2 24 | $416.0M | $547.4M | ||
| Q1 24 | $345.0M | $540.9M |
总债务ELANRHI
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
股东权益ELANRHI
| Q4 25 | $6.5B | $1.3B | ||
| Q3 25 | $6.7B | $1.3B | ||
| Q2 25 | $6.8B | $1.3B | ||
| Q1 25 | $6.4B | $1.3B | ||
| Q4 24 | $6.1B | $1.4B | ||
| Q3 24 | $6.5B | $1.5B | ||
| Q2 24 | $5.9B | $1.5B | ||
| Q1 24 | $6.1B | $1.5B |
总资产ELANRHI
| Q4 25 | $13.4B | $2.9B | ||
| Q3 25 | $13.6B | $2.8B | ||
| Q2 25 | $13.7B | $2.8B | ||
| Q1 25 | $12.9B | $2.7B | ||
| Q4 24 | $12.6B | $2.9B | ||
| Q3 24 | $13.3B | $3.0B | ||
| Q2 24 | $13.8B | $2.9B | ||
| Q1 24 | $14.0B | $2.9B |
负债/权益比ELANRHI
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $170.8M |
| 自由现金流率自由现金流/营收 | 4.0% | 13.1% |
| 资本支出强度资本支出/营收 | 5.4% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $284.0M | $266.8M |
8季度趋势，按日历期对齐
经营现金流ELANRHI
| Q4 25 | $108.0M | $182.5M | ||
| Q3 25 | $219.0M | $77.4M | ||
| Q2 25 | $237.0M | $119.4M | ||
| Q1 25 | $-4.0M | $-59.3M | ||
| Q4 24 | $177.0M | $154.8M | ||
| Q3 24 | $162.0M | $129.6M | ||
| Q2 24 | $200.0M | $142.0M | ||
| Q1 24 | $2.0M | $-15.9M |
自由现金流ELANRHI
| Q4 25 | $46.0M | $170.8M | ||
| Q3 25 | $127.0M | $63.6M | ||
| Q2 25 | $180.0M | $104.2M | ||
| Q1 25 | $-69.0M | $-71.7M | ||
| Q4 24 | $130.0M | $140.5M | ||
| Q3 24 | $120.0M | $111.8M | ||
| Q2 24 | $166.0M | $129.6M | ||
| Q1 24 | $-22.0M | $-27.7M |
自由现金流率ELANRHI
| Q4 25 | 4.0% | 13.1% | ||
| Q3 25 | 11.2% | 4.7% | ||
| Q2 25 | 14.5% | 7.6% | ||
| Q1 25 | -5.8% | -5.3% | ||
| Q4 24 | 12.7% | 10.2% | ||
| Q3 24 | 11.7% | 7.6% | ||
| Q2 24 | 14.0% | 8.8% | ||
| Q1 24 | -1.8% | -1.9% |
资本支出强度ELANRHI
| Q4 25 | 5.4% | 0.9% | ||
| Q3 25 | 8.1% | 1.0% | ||
| Q2 25 | 4.6% | 1.1% | ||
| Q1 25 | 5.4% | 0.9% | ||
| Q4 24 | 4.6% | 1.0% | ||
| Q3 24 | 4.1% | 1.2% | ||
| Q2 24 | 2.9% | 0.8% | ||
| Q1 24 | 2.0% | 0.8% |
现金转化率ELANRHI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | 21.55× | 2.91× | ||
| Q1 25 | -0.06× | -3.42× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.45× | 1.98× | ||
| Q2 24 | — | 2.08× | ||
| Q1 24 | 0.06× | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
